These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1715487)

  • 21. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment.
    Aalkjaer C; Eiskjaer H; Mulvany MJ; Jespersen B; Kjaer T; Sørensen SS; Pedersen EB
    J Hypertens; 1989 Apr; 7(4):305-10. PubMed ID: 2723429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic resistance of forearm vessels during prolonged drug treatment of essential hypertension.
    Vitols AV; Skarda IJ; Liepinia DJ; Voita DU; Skards JV
    Cor Vasa; 1990; 32(1):36-44. PubMed ID: 2340728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].
    Moreau P; Takase H; Küng CF; Lüscher TF
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1141-3. PubMed ID: 8572861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance vessels in hypertension.
    Halpern W; Osol G
    Prog Clin Biol Res; 1986; 219():211-23. PubMed ID: 3538026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Media hypertrophy in hypertensive coronary resistance vessels.
    Klepzig M; Eisenlohr H; Steindl J; Schmiebusch H; Strauer BE
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S97-102. PubMed ID: 2485036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regression of vascular remodeling in renovascular hypertensive rats by tetrandrine and enalapril].
    Li QP; Leng J; Peng T; Rao MR
    Yao Xue Xue Bao; 2003 May; 38(5):328-32. PubMed ID: 12958833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular growth in hypertension.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S7-11. PubMed ID: 1380621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small artery remodelling in hypertension.
    Mulvany MJ
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):49-55. PubMed ID: 21733124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are vascular abnormalities a primary cause or secondary consequence of hypertension?
    Mulvany MJ
    Hypertension; 1991 Sep; 18(3 Suppl):I52-7. PubMed ID: 1889858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development and regression of vascular hypertrophy.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S22-7. PubMed ID: 1377300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes to the vascular system resulting from hypertension and their effects on response to therapy.
    Mulvany MJ
    Drugs; 1990; 39 Suppl 1():9-20. PubMed ID: 2407496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural alterations in small resistance arteries in obesity.
    Rizzoni D; De Ciuceis C; Porteri E; Semeraro F; Rosei EA
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):56-62. PubMed ID: 21883940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting vascular structure for the treatment of sexual dysfunction.
    Hale TM; Hannan JL; Carrier S; deBlois D; Adams MA
    J Sex Med; 2009 Mar; 6 Suppl 3():210-20. PubMed ID: 19207270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance vessel structure and the pathogenesis of hypertension.
    Mulvany MJ
    J Hypertens Suppl; 1993 Dec; 11(5):S7-12. PubMed ID: 8158439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic consequences of resistance vessel rarification and of changes in smooth muscle sensitivity.
    Hallbäck M; Göthberg G; Lundin S; Ricksten SE; Folkow B
    Acta Physiol Scand; 1976 Jun; 97(2):233-40. PubMed ID: 949008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplifier function of resistance vessels and the left ventricle in hypertension.
    Korner PI; Angus JA; Bobik A; Jennings GL
    J Hypertens Suppl; 1991 Dec; 9(2):S31-40; discussion S40-1. PubMed ID: 1838766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.